• EPH174 Adverse Events Associated with COVID-19 and Seasonal Influenza Vaccines: A Retrospective and Descriptive Analysis of CDC/FDA Vaccine Adverse Event Reporting System (VAERS) Reports

    Jul 1, 2022, 00:00

  • EE236 Cost-Effectiveness of Ceftazidime/Avibactam Versus Meropenem in the Treatment of Complicated Intra-Abdominal Infections in China

    Jul 1, 2022, 00:00

  • EE170 Implementation of an Evidence-Based, Software Application to Compare Automation Blood Processing Systems (ABPS) Vs. Semi-Automated Blood Processing Systems

    Jul 1, 2022, 00:00

  • HTA67 US Icer's Assessments to Date Indicate Price Cuts Required for 90% of Drugs, but HTA Framework Not Consistently Applied in 37% of Reviews

    Jul 1, 2022, 00:00

  • EPH31 Disparities and Trends of COVID-19 Epidemiology in EU-5 Countries across Pandemic Waves: A Targeted Literature Review (TLR)

    Jul 1, 2022, 00:00

  • HSD66 Impact of Lunar Phases on Incidences of Cerebro-Cardiovascular Diseases

    Jul 1, 2022, 00:00

  • HSD20 Examining the Effect of Infection Prevention and Control Awareness Among Nurses on Patient and Family Education: A Cross-Sectional Study

    Jul 1, 2022, 00:00

  • CO95 A Matching-Adjusted Indirect Comparison of Filgotinib Versus Tofacitinib for Moderately to Severely Active Ulcerative Colitis

    Jul 1, 2022, 00:00

  • EPH4 Incidence and Survival of Patients with Hepatocellular Carcinoma in the United States from 2008 to 2018

    Jul 1, 2022, 00:00

  • EE141 Cost Analysis of Heart Failure Management in Malaysia: A Multi-Centered Retrospective Study

    Jul 1, 2022, 00:00

  • CO135 Hospitalization and Exacerbation Estimates of Efgartigimod Vs. Conventional Therapy in Generalized Myasthenia Gravis Patients: A Post-Hoc Analysis of the Phase 3 ADAPT Study

    Jul 1, 2022, 00:00

  • EE76 Budget Analysis of Etonogestrel Subdermal Contraceptive Implant (ESI) Compared to Levonorgestrel Intrauterine Device (LNG-IUD) Reimbursed on the Brazilian Private Health Insurance and Plans

    Jul 1, 2022, 00:00

  • EE432 Cost-Effectiveness Analysis of Sacubitril/Valsartan in Implantable Cardioverter-Defibrillator Eligible Patients

    Jul 1, 2022, 00:00

  • HPR14 Relationship/Association between Clinical Potential of Orphan Drugs and Registration Status Assigned By the European Medicines Agency: Selected Aspects

    Jul 1, 2022, 00:00

  • HSD31 Treatment Patterns of Relapsing-Remitting Multiple Sclerosis within the High Cost Drug Law (RICARTE SOTO LAW) Program in Chile from July 2017 to November 2021

    Jul 1, 2022, 00:00

  • EE349 Remdesivir Use in Hospitalized COVID-19 Patients in the United Arab Emirates: A Cost-Effectiveness and Health Care Resource Use Model

    Jul 1, 2022, 00:00

  • EE39 Costs of Treating Hereditary Angioedema (HAE) Attacks with C1 Inhibitors in Four European Countries

    Jul 1, 2022, 00:00

  • EE335 The Hospitalization Burden of COVID-19 in Patients with NSCLC: Differential Impact of Vaccination

    Jul 1, 2022, 00:00

  • EE463 Health Care Use and Costs Among Individuals Receiving Integrated Mental Health Services for Depression in Nepal

    Jul 1, 2022, 00:00

  • CO99 Chimeric Antigen Receptor T-Cell Therapy (CAR-T) Utilization Patterns for Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Among United States (US) Community Hematologists/Oncologists (CH/OS)

    Jul 1, 2022, 00:00

  • HTA73 Payer Perceptions of ICER's Impact on Rare Disease Assessment

    Jul 1, 2022, 00:00

  • HTA5 Cost-Utility Analysis of Dapagliflozin in Patients with Chronic Kidney Disease in Panama

    Jul 1, 2022, 00:00

  • Epidemiology Public Health

    Jul 1, 2022, 00:00

  • P3 An Assessment of Barriers to Fair Access to Cost-Effective Drugs

    Jul 1, 2022, 00:00

  • EPH40 Characteristics of COVID-19 Patients Admitted to the University Hospital of El Biar in Algiers during the First 6 Months of the Epidemic in Algeria: Descriptive Study of 1008 Cases

    Jul 1, 2022, 00:00

  • Does Changing the Age of a Child to be Considered in 3-Level Version of EQ-5D-Y Discrete Choice Experiment–Based Valuation Studies Affect Health Preferences?

    Jul 1, 2022, 00:00

  • CO127 Systematic Literature Review (SRL) of Comparative Safety and Effectiveness of Hormonal LARCs

    Jul 1, 2022, 00:00

  • HPR24 Changes in Number of Practising Nurses in Eastern and Western Europe

    Jul 1, 2022, 00:00

  • EE295 Cost-Effectiveness Analysis of Switching from BASAL Insulin + ORAL Antidiabetics - GLP1-RA to Ideglira in Brazil

    Jul 1, 2022, 00:00

  • P8 Patient Prioritisation of Items for the New Patient-Reported Impact of Dermatological Diseases (PRIDD) Measure: A Delphi Study

    Jul 1, 2022, 00:00

  • EE381 Comparative Cost Effectiveness of Dapagliflozin and Empagliflozin in Heart Failure with Reduced Ejection Fraction

    Jul 1, 2022, 00:00

  • EE126 Cost Drivers in Patients with Classic Congenital Adrenal Hyperplasia (CAH)

    Jul 1, 2022, 00:00

  • EE54 A Cost Effectiveness Analysis of Emergency Departments Compared to Urgent Care Centers Among Medicare Beneficiaries

    Jul 1, 2022, 00:00

  • EE79 A Cost of Control Analysis of Once-Weekly Subcutaneous Semaglutide Versus Dulaglutide for Bringing Patients to Treatment Targets in China

    Jul 1, 2022, 00:00

  • MSR19 A Matching-Adjusted Indirect Comparison of Asciminib Versus Ponatinib, Nilotinib and Dasatinib in Chronic Phase Chronic Myeloid Leukemia Patients after ≥2 Tyrosine Kinase Inhibitors

    Jul 1, 2022, 00:00

  • EE379 Cataloguing Health State Utilities for Lower Extremity Peripheral Artery Disease

    Jul 1, 2022, 00:00

  • EE384 Cost of Medication Non-Adherence Among Patients on Immunosuppressants

    Jul 1, 2022, 00:00

  • HSD121 Atopic Dermatitis Disease Activity and Initiation of Systemic Therapy in the Real-World Setting

    Jul 1, 2022, 00:00

  • EE247 Healthcare Expenditures of Autistic Individuals

    Jul 1, 2022, 00:00

  • HSD72 Identification of Uncomplicated DVT Patient Characteristics Treated in the Outpatient Setting

    Jul 1, 2022, 00:00

  • EPH128 Hospitalizations Caused By Infections with Carbapenem-Resistant, Gram-Negative Bacteria in Germany: An Epidemiologic Analysis Using Claims Data from Different Sources

    Jul 1, 2022, 00:00

  • HSD78 Diagnosis and Treatment Patterns of GERD in Non-Gastrointestinal Departments in China: A Subgroup Analysis from a Retrospective Real-World Study (GRAND CHINA)

    Jul 1, 2022, 00:00

  • EE268 Budget Impact Analysis for the Use of Sodium Phenylacetate and Sodium Benzoate in the Treatment of Acute Hyperammonemia: Experience in a Saudi Setting

    Jul 1, 2022, 00:00

  • HTA62 Evaluating the Gaps in Health Technology Assessment (HTA) Requirements: A Comparative Analysis of HTA Systems of Europe, Canada, and United States with Asia Pacific Region

    Jul 1, 2022, 00:00

  • EE505 Canada's Evolving Market for Biosimilars and What It Means for Payers

    Jul 1, 2022, 00:00

  • EE197 Cost-Effectiveness Analysis of Trastuzumab Emtansine Versus Pertuzumab with Trastuzumab for Chinese Patients with Residual Invasive HER2-Positive Early Breast Cancer

    Jul 1, 2022, 00:00

  • EE328 Cost-Effectiveness of a Nursing Intervention in the Maintenance of Blood Pressure Control

    Jul 1, 2022, 00:00

  • P75 Impact of High-Dose Vs Standard-Dose Influenza Vaccine on Respiratory Hospitalizations Among Adults

    Jul 1, 2022, 00:00

  • CO136 COVID-19 Pandemic Indirect Impact on Mortality Rates

    Jul 1, 2022, 00:00

  • EE299 Budget Impact Analysis of Sentinel Prostate Test Versus Current Diagnostic Strategy for Men with Suspicion of Prostate Cancer in the US

    Jul 1, 2022, 00:00

  • EE282 Incremental Net Monetary Benefit of Direct Oral Anticoagulants for the Prevention of Venous Thromboembolism after Total Knee or Hip Replacement: A Systematic Review and Meta-Analysis

    Jul 1, 2022, 00:00

  • HSD4 Impact of Specialty Pharmacy Collaboration with Rheumatology Clinics to Improve the Achievement of Treat-to-Target Goals in Patients with Rheumatoid Arthritis

    Jul 1, 2022, 00:00

  • MSR33 Physicians' Assessment of the Clinical Utility of a Novel Test to Diagnose Alzheimer's Disease (AD)

    Jul 1, 2022, 00:00

  • HPR26 Pricing, Reimbursement and Market Access Trends for Cell and Gene Therapies in the US and Europe

    Jul 1, 2022, 00:00

  • EPH87 Participation in Cervical Cancer Screening in Hungary

    Jul 1, 2022, 00:00

  • EPH119 Patient Characteristics, Outcomes, and Hospital Resource Utilization Associated with Surgical Mitral Ring Annuloplasty

    Jul 1, 2022, 00:00

  • MSR5 Visualizing Network Meta-Analyses is not Trivial - A Novel Take on the Network Diagram

    Jul 1, 2022, 00:00

  • Affordability and Value in Decision Rules for Cost-Effectiveness: A Survey of Health Economists

    Jul 1, 2022, 00:00

  • EE421 Burden of Illness Related to Motor Function in Types 2 and 3 Spinal Muscular Atrophy (SMA)

    Jul 1, 2022, 00:00

  • P42 Direct and Indirect Costs Associated with Major Depressive Disorder

    Jul 1, 2022, 00:00

  • EE9 Real-World Naloxone Prescription Trends, Costs, and Comorbidities in Commercial, Managed Medicare, and Medicaid Patients in the United States (2016-2019)

    Jul 1, 2022, 00:00

  • MSR43 Extracting Severity Markers from Unstructured Clinical Data of Congestive Heart Failure Patients Using a Pretrained Text-to-Text Transfer Transformer Model

    Jul 1, 2022, 00:00

  • EE311 Cost-Effectiveness Analysis of Ruxolitinib vs Best Available Therapy for the Treatment of Myelofibrosis in the United States

    Jul 1, 2022, 00:00

  • EE448 Cost-Utility Analysis of Benralizumab in Severe Eosinophilic Asthma in Panama

    Jul 1, 2022, 00:00

  • EPH163 Risk of Memantine Initiation with Use of Antimuscarinics and/or Cholinesterase Inhibitors in Older Adults with Alzheimer's Disease

    Jul 1, 2022, 00:00

  • P62 Cost-Effectiveness of Atezolizumab Plus Cobimetinib and Vemurafenib in the Treatment of BRAF V600 Mutation-Positive Metastatic Melanoma

    Jul 1, 2022, 00:00

  • CO87 Treatment Patterns and Costs Associated with Small Cell Lung Cancer in a U.S. Medicare Population

    Jul 1, 2022, 00:00

  • HSD51 Increasing Dialysis Program Sustainability through a Technology Enabled, High-Efficiency Staffing Model

    Jul 1, 2022, 00:00

  • HTA23 Value from a Multi-Stakeholder Perspective: A Framework to Assess Digital Health Solutions for Improving Chronic Disease Management

    Jul 1, 2022, 00:00

  • HTA38 Characterizing Evidentiary Criteria in HTA Assessments of CAR-T Therapies

    Jul 1, 2022, 00:00

  • EE398 Cost-Utility Analysis of Academic Detailing Outreach on Naloxone Prescribing for Patients at Risk of Opioid-Related Overdose or Death

    Jul 1, 2022, 00:00

  • EE31 Cost-Utility Analysis of Dapagliflozin in Patients with Chronic Kidney Disease in Dominican Republic

    Jul 1, 2022, 00:00

  • EE193 The Health Impact Projection Model of the PD-1/PD-L1 Inhibitor Class in Cancer Care in Turkey

    Jul 1, 2022, 00:00

  • EE468 Economic Impact of Sequential Testing for COVID-19 and Influenza with Molecular Point of Care in 3 European Countries

    Jul 1, 2022, 00:00

  • EE370 Assessing the Impact of Crossover Adjustment on the Cost-Effectiveness (CE) of Nivolumab Versus Everolimus in Pre-Treated Advanced Renal Cell Carcinoma (ARCC) in the United States (US)

    Jul 1, 2022, 00:00

  • EE187 US Price Trends over the Drug Life Cycle: Examples and Policy Implications

    Jul 1, 2022, 00:00

  • P23 Machine Learning Approaches to Evaluate Treatment Switching in Patients with Multiple Sclerosis: Analyses of Electronic Medical Records

    Jul 1, 2022, 00:00

  • EPH22 Prevalence and Risk Factors of Post COVID-19 Condition in Previously Hospitalized Patients in Bolivar, Colombia: An Observational Study

    Jul 1, 2022, 00:00

  • EE205 Cost-Effectiveness Analysis of Empagliflozin Versus Albiglutide Among Individuals with Type 2 Diabetes in the US

    Jul 1, 2022, 00:00

  • CO17 Impact of Huntington's Disease on Driving: A Review of Driving Simulator Measures and Association with Clinical Outcomes Assessments

    Jul 1, 2022, 00:00

  • EE169 Impact of Adherence to Novel Hormonal Therapies on Emergency Department Utilization in Patients with Metastatic Castration-Resistant Prostate Cancer

    Jul 1, 2022, 00:00

  • HSD47 Malignant Surgical Volumes and Length of Stay By Modality during the COVID-19 Pandemic

    Jul 1, 2022, 00:00

  • HPR11 Multicriteria Decision Analysis (MCDA) to Identify Criteria for Guiding Decision Making for Post-Menopausal Osteoporosis Treatment in the Brazilian Public Healthcare System

    Jul 1, 2022, 00:00

  • Machine Learning Methods in Health Economics and Outcomes Research—The PALISADE Checklist: A Good Practices Report of an ISPOR Task Force [Editor's Choice]

    Jul 1, 2022, 00:00

  • HSD65 Differences in Demand of Domestic and Foreign Patients in Hungary's Dental Tourism

    Jul 1, 2022, 00:00

  • EPH48 Operationalizing the 2019 GINA Asthma Treatment Steps for Application to Real-World Data from the UK

    Jul 1, 2022, 00:00

  • MSR54 Multi-Task Learning in Click-through-Probability (Multi-CTP) Prediction for Real-World Digital Content Recommendation

    Jul 1, 2022, 00:00

  • EE493 A Budget Impact Model for Tiotropium/Olodaterol Versus Fixed-Dose Combination Triple Therapy in Patients with COPD

    Jul 1, 2022, 00:00

  • EE425 Cost-Effectiveness Analysis of Rivaroxaban Vs Other Anticoagulants

    Jul 1, 2022, 00:00

  • EE62 Direct and Indirect Costs of Multiple Sclerosis in China

    Jul 1, 2022, 00:00

  • EE304 IDegAsp Treatment Was Associated with Reduced Healthcare Resource Utilization in Adults with Type 2 Diabetes: A Real-World Study

    Jul 1, 2022, 00:00

  • CO109 Increase in All-Cause Mortality Rate for Patients Admitted to the Emergency Department (ED) with Myocardial Infarcts during COVID-19 Pandemic Regardless of ST Elevation

    Jul 1, 2022, 00:00

  • EE404 Associations of Comprehensive Stroke Center Scores with Medical and Long-Term Care Expenditures in Ischemic Stroke Patients after Hospital Discharge: J-Aspect Life Study

    Jul 1, 2022, 00:00

  • EE133 COST-EFFECTIVENESS ANALYSIS OF PAZOPANIB VERSUS SUNITINIB FOR THE TREATMENT OF FIRST-LINE ADVANCED AND/OR METASTATIC RENAL CELL CARCINOMA IN CHINA: USING PARTITIONED SURVIVAL MODEL AND MARKOV MODEL

    Jul 1, 2022, 00:00

  • CO63 Vestibular Symptoms, Hearing Preservation, and Facial Symmetry in Surgery Vs SRS for Vestibular Schwannomas: A Systematic Review and Meta-Analysis

    Jul 1, 2022, 00:00

  • EPH60 Real-World Data Dashboard Integrating Public Health EHR Data for Identifying COVID-19 Vaccination Gaps in the US

    Jul 1, 2022, 00:00

  • EE487 The Economic Burden Associated with Stillbirth: A Systematic Review

    Jul 1, 2022, 00:00

  • HTA39 Characterization, Measurement, and Valuation of Attributes of Innovation of Technologies for Healthcare: A Systematic Review

    Jul 1, 2022, 00:00

  • EE95 Cost-Effectiveness Analysis of the Colorectal Cancer Screening Program Using Electronic Colonoscopy in Luohu, China

    Jul 1, 2022, 00:00

  • EE185 Healthcare Resource Utilization in US Clinical Practice Among Patients with von Willebrand Disease

    Jul 1, 2022, 00:00

  • EE344 Estimating the Utilization of and Expenditure on the Newly Approved Injectable Prep Required to Meet the "End the HIV Epidemic in the US” 2030 Goal of 90% Reduction in New HIV Infections

    Jul 1, 2022, 00:00

  • P56 Patient Preferences in Multiple Myeloma: A Discrete Choice Experiment

    Jul 1, 2022, 00:00

  • EE316 End-of-Life Costs in Multiple Sclerosis: An Analysis of Medicare Claims Data

    Jul 1, 2022, 00:00

  • HSD9 The Deployment of Balanced Scorecard in Health Care Organizations: Is It Beneficial? A Systematic Review

    Jul 1, 2022, 00:00

  • EE378 Economic Burden of Spinal Muscular Atrophy from the Perspective of Public Health Institutions in Mexico

    Jul 1, 2022, 00:00

  • Health Policy Regulatory

    Jul 1, 2022, 00:00

  • HTA35 Testing and Piloting of a Value Framework for Diagnostic Technologies in Latin America

    Jul 1, 2022, 00:00

  • CO113 Clinical Outcomes of Patients with Hemophilia Receiving Different Treatment Regimens in China: Based on Patient-Reported Data

    Jul 1, 2022, 00:00

  • P12 Development of the Medication Access Screening Tool (RXMAST) in Patients with Chronic Diseases: A Qualitative Study

    Jul 1, 2022, 00:00

  • EE389 Social and Economic Impact of Adverse Events in Switching from Pentavalent Whole Cell Pertussis to Hexavalent Acellular Vaccine for All Infants in Brazil

    Jul 1, 2022, 00:00

  • EE306 Cost-Effectiveness Analysis of Treatments in Chronic Kidney Disease in Mexico

    Jul 1, 2022, 00:00

  • EPH13 Mortality from Ischaemic Heart Disease Among Men in Hungary By County

    Jul 1, 2022, 00:00

  • EPH108 CO-Morbidities and Mechanistic Similarities of Essential Tremor and Parkinson's Disease and Resulting Diagnostic Challenges

    Jul 1, 2022, 00:00

  • MSR25 Prescription Nsaids and Incident Cancer Among Older Adults with Osteoarthritis: Application of Machine Learning Methods

    Jul 1, 2022, 00:00

  • EPH172 When Is It Valuable for COVID-19 Booster Dose?: A Transmission Dynamics Model-Based Effectiveness and Cost-Effectiveness Analysis of Two Booster Dose Vaccination Priority Strategies in Mainland China

    Jul 1, 2022, 00:00

  • HSD50 Evaluation of Utilization Patterns of Cough Medications in Ambulatory Care Settings in the United States: 2003-2018

    Jul 1, 2022, 00:00

  • HSD98 Estimating the Impact of the COVID-19 Pandemic on Healthcare Waiting Lists in England

    Jul 1, 2022, 00:00

  • EE431 Description of Clinical Pharmacists Reported Interventions to Prevent Adverse Drug Events Among Patients with Cardiovascular Disease

    Jul 1, 2022, 00:00

  • P72 Designing a Value-Based Formulary for Kaiser Permanente Washington: A Hypothetical Case Study of Diabetes Mellitus Medications

    Jul 1, 2022, 00:00

  • HSD55 Non-Interventional, Real-World Study of Patients with Early Stage, Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Receiving Biosimilar Trastuzumab

    Jul 1, 2022, 00:00

  • HTA43 The Practice of Drug Clinical Comprehensive Evaluation in China and the Implications in Patient Access to Innovative Drugs

    Jul 1, 2022, 00:00

  • EPH23 Sociodemographic and Clinical Characteristics of Patients with Atopic Dermatitis in Colombia:Preliminary Results of Rendac

    Jul 1, 2022, 00:00

  • EE272 Economic Burden Associated with ISO-Osmolar Versus Low Osmolar Iodinated Contrast Media during Peripheral Endovascular Procedures: Evidence from Premier Database

    Jul 1, 2022, 00:00

  • P39 The Humanistic Burden of Transfusion-Dependent Lower-Risk Myelodysplastic Syndromes on Patients and Caregivers: Qualitative Research Findings

    Jul 1, 2022, 00:00

  • HSD7 Does Clinical Evidence of Heterogeneity Influence Treatment Selection? a Case Study of Abiraterone Acetate for Metastatic Castration-Sensitive Prostate Cancer

    Jul 1, 2022, 00:00

  • EE394 Outcomes and Costs Associated with Central Venous Catheter-Related S. Aureus Bloodstream Infections in Adult Hemodialysis Patients with S. Aureus Nares Colonization

    Jul 1, 2022, 00:00

  • Analytic Studies in Patient-Centered Research

    Jul 1, 2022, 00:00

  • An Analysis of 5-Level Version of EQ-5D Adjusting for Treatment Switching: The Case of Patients With Epidermal Growth Factor Receptor T790M-Positive Nonsmall Cell Lung Cancer Treated With Osimertinib

    Jul 1, 2022, 00:00

  • EE455 Clinical and Economic Utility of a Proteomic Biomarker Preterm Birth Predictor: Analysis of a Large and Diverse Pregnancy Cohort

    Jul 1, 2022, 00:00

  • CO98 Midodrine Use As an Adjunct Therapy to Intravenous Vasopressors in Critically Ill Patients

    Jul 1, 2022, 00:00

  • EPH97 Routine Vaccination Coverage in EL Carmen De Bolivar, Colombia: A Survey of Children Under 6 Years of Age, 2021

    Jul 1, 2022, 00:00

  • EE442 The Cost-Effectiveness of Risk Stratified Breast Cancer Screening in the UK

    Jul 1, 2022, 00:00

  • HSD18 High Willingness to Deprescribe Among People Living with Dementia and Mild Cognitive Impairment

    Jul 1, 2022, 00:00

  • EE142 Cost-Effectiveness Analysis of Biosimilars Based Treatment Sequences for Moderate-to-Severe Crohn Disease in Spain

    Jul 1, 2022, 00:00

  • HSD127 Impact of a GI Clinic-Embedded Pharmacist on Hepatic Encephalopathy Healthcare Resource Utilization, Mortality, and MELD Score

    Jul 1, 2022, 00:00

  • EE476 Cost-Effectiveness of Emicizumab Prophylaxis in Patients with Hemophilia a without Inhibitors

    Jul 1, 2022, 00:00

  • P71 Inpatient and Outpatient Medical Costs, Hospitalizations, and Length of Stay Associated with Adherence to Non-cycled Oral Antineoplastics Among Oncology Patients

    Jul 1, 2022, 00:00

  • EPH82 Impact of HPV Vaccination on Cervical Cancer Incidence Among Females 15-34 Years Old, 2001-2018

    Jul 1, 2022, 00:00

  • EPH115 Recent Trends in Preterm Birth and Its Clinical Subtypes: Race/Ethnicity

    Jul 1, 2022, 00:00

  • EE439 An MCDA Preference Index Support for the ICUR Analysis Between Psoriatic Arthritis Treatments

    Jul 1, 2022, 00:00

  • EE326 Financial Impact of a Femur Fracture Secondary to Osteoporosis in Women over 60 Years Old Under Private Health Insurance in Brazil

    Jul 1, 2022, 00:00

  • EE200 Economic Evaluation of an Opportunistic Screening Program for Alzheimer's Disease in Luohu, China

    Jul 1, 2022, 00:00

  • EE226 A US Claims Database Analysis of the Impact of Fremanezumab on Migraine-Related Health Care Utilization and Costs in Patients with Common Comorbidities, Acute Medication Overuse, or Difficult-to-Treat Migraine Following Prior Erenumab ...

    Jul 1, 2022, 00:00

  • MSR20 Challenges in the Development of Economic Evaluations for Psychedelics in Treatment of Depression

    Jul 1, 2022, 00:00

  • EE148 Budget Impact Analysis of Outpatient Nutrition Program for Adults at Nutritional Risk

    Jul 1, 2022, 00:00

  • EPH143 Time Trend of Incidence Rates in Cancers with and without Commonly Adopted Guideline-Recommended Screening (CGRS) in the United States, 2000-2018

    Jul 1, 2022, 00:00

  • HSD44 Community Hematologist/Oncologist (CH/O) Barriers to CAR T Referral and Concerns with Possible in-Office CAR-T Administration

    Jul 1, 2022, 00:00

  • EE237 The Risk-Based Pri Incorporating Uncertainty and Risk Attitues in Health Technology Pricing

    Jul 1, 2022, 00:00

  • EE228 Cost-Effectiveness Analysis of the 25 Fraction Versus 5 Fraction Radiotherapy Regimens for Early Breast Cancer

    Jul 1, 2022, 00:00

  • CO65 Estimating the Number of Individuals Needed to Treat with Different Pre-Exposure Prophylaxis Options to Avoid 1 New HIV-1 Infection in the United States

    Jul 1, 2022, 00:00

  • EE25 Economic Evaluation on the Use of Standard Lyophilized Bacterial Lysates for Recurrent Respiratory Infections Prevention in Pediatric Patients

    Jul 1, 2022, 00:00

  • EE280 Budget Impact (BI) of First-Line (1L) Cemiplimab Monotherapy for Advanced Non-Small Cell Lung Cancer (aNSCLC) with Programmed Cell Death-Ligand 1 (PD-L1) ≥50% in a Large US Health Plan: An Updated Analysis

    Jul 1, 2022, 00:00

  • EE114 A Cost-Effectiveness Analysis of Dental Caries Prevention Strategies in U.S. Children

    Jul 1, 2022, 00:00

  • HPR71 Regulatory Journey on Vaccination Against COVID-19 in Brazil

    Jul 1, 2022, 00:00

  • EPH63 Identification of a Warm Autoimmune Hemolytic Anemia (wAIHA) Population Using Predictive Analytics of a Known Clinically Profiled Cohort

    Jul 1, 2022, 00:00

  • EPH66 Descriptive Analysis of Adverse Events Reported Associated with the Use of Tigecycline or Minocycline Using the FDA Adverse Event Reporting System Database from 2008 to 2021

    Jul 1, 2022, 00:00

  • EE179 Key Drivers of the Economically Justifiable Price of the COVID-19 Vaccine in England

    Jul 1, 2022, 00:00

  • Applications of Discrete Choice Experiments for Patient Preference Elicitation

    Jul 1, 2022, 00:00

  • EE465 A USRDS Retrospective Cohort Study: Epidemiology, Treatment Modalities, and Burden of End-Stage Kidney Disease Attributed to Focal Segmental Glomerulosclerosis (FSGS)

    Jul 1, 2022, 00:00

  • Cost-Effectiveness of Midazolam Versus Haloperidol Versus Olanzapine for the Management of Acute Agitation in the Accident and Emergency Department

    Jul 1, 2022, 00:00

  • EE452 Efficacy and Cost Effectiveness of Biological Agents in Moderate to Severe Psoriatic Arthritis: A Meta-Analysis

    Jul 1, 2022, 00:00

  • P10 Parental Vaccine Sentiment and Decision-Making Factors for Pediatric COVID-19 Vaccinations

    Jul 1, 2022, 00:00

  • CO34 Types of Usual Source of Care and Their Association with Healthcare Outcomes Among Cancer Survivors: A Medical Expenditure Panel Survey (MEPS) Study

    Jul 1, 2022, 00:00

  • EPH2 Adverse Outcomes Associated with Concurrent Gabapentin, Opioid, and Benzodiazepine Utilization: A Nested Case-Control Study

    Jul 1, 2022, 00:00

  • MSR40 Predictive Modeling of the 30-Day Behavioral Health Readmission Risk in a Medicaid Population

    Jul 1, 2022, 00:00

  • HSD122 Informal Unpaid Caring and Mental Health of Caregivers in Scotland

    Jul 1, 2022, 00:00

  • HSD5 Changes in COVID-19 Treatment Patterns over the Course of 2020

    Jul 1, 2022, 00:00

  • EE363 Improved Therapeutic Approaches Are Needed to Minimise the Burden of Graft-Versus-Host Disease

    Jul 1, 2022, 00:00

  • EE188 COVID-19 Vaccine Hesitancy Among Early Adaptors in Jordan

    Jul 1, 2022, 00:00

  • HTA54 A Conceptual Model for Calculating the Carbon Footprint of Chronic Kidney Disease

    Jul 1, 2022, 00:00

  • CO139 Use of Remdesivir Among Hospitalized Patients with Severe COVID-19: Analysis of Electronic Health Records from Trinetx COVID-19 Network

    Jul 1, 2022, 00:00

  • Emerging Evidence on Sars-COV2 Vaccine Utilization and Outcomes

    Jul 1, 2022, 00:00

  • HTA34 The Role of the Mainz Severity Score Index (MSSI) on Disease Related-Clinical Events in Patients with Fabry Disease

    Jul 1, 2022, 00:00

  • EE329 Early Albumin Infusion in Cirrhotic Patients with Spontaneous Bacterial Peritonitis (SBP) Is Associated with Reductions in Total Hospitalization Costs: A Cross-Sectional Study

    Jul 1, 2022, 00:00

  • EE395 Cost-Effectiveness of Respiratory Syncytial Virus Prophylaxis in Preterm Infants 29-35 Weeks' Gestation

    Jul 1, 2022, 00:00

  • HTA29 Value Assessment Framework of Therapeutic Medical Devices in China - Based on Seven-Country Health Technology Assessment Guidelines

    Jul 1, 2022, 00:00

  • P55 A Discrete Choice Experiment of Patient-Informed Preferences for Major Depressive Disorder Treatment

    Jul 1, 2022, 00:00

  • EPH153 A Population-Based Study of the Epidemiology, Healthcare Resource Utilization and Costs of Duchenne Muscular Dystrophy in Alberta, Canada

    Jul 1, 2022, 00:00

  • P28 Socioeconomic Disparities in Ischemic Stroke Care: Imaging and Acute Treatment Utilization from a Comprehensive Stroke Center

    Jul 1, 2022, 00:00

  • EPH105 Variables Associated with Frequent Exercise Among us Adults with Asthma

    Jul 1, 2022, 00:00

  • The Cost-Effectiveness of Intermediate-Acting, Long-Acting, Ultralong-Acting, and Biosimilar Insulins for Type 1 Diabetes Mellitus: A Systematic Review

    Jul 1, 2022, 00:00

  • EPH33 Systematic Review of Ntrk Fusion Prevalence across Cancer Types to Predict Impact of Histology Independent Cancer Treatment

    Jul 1, 2022, 00:00

  • HEOR Studies in Medication Management

    Jul 1, 2022, 00:00

  • P67 Short-Term Cost-Effectiveness of a Remote Robotic Mechanical Thrombectomy System

    Jul 1, 2022, 00:00

  • EE447 Cost Implications of Adverse Event Profiles in Second Generation Androgen Receptor Inhibitor (SGARI) Treatments for Non-Metastatic Castration Resistant Prostate Cancer (NMCRPC)

    Jul 1, 2022, 00:00

  • EE361 Preliminary Cost-Effectiveness Analysis of Proton Beam Therapy in Patients with Hepatocellular Carcinoma in Japan

    Jul 1, 2022, 00:00

  • HTA2 RAPID C-19: Achievements and Challenges of a Collaborative Response to the COVID-19 Pandemic in the UK

    Jul 1, 2022, 00:00

  • EPH152 Epidemiological Disease Burden of Malignant Neoplasm of Other and Ill-Defined Sites in the Lip, Oral Cavity and Pharynx Based on Routinely Collected Health Insurance Claims Data

    Jul 1, 2022, 00:00

  • HPR70 The Influence of Medicare Reimbursement Policy of DAAs for Hepatitis C Virus on Health and Economic Burden: A Case Study in Chengdu, China

    Jul 1, 2022, 00:00

  • HPR17 Racial and Ethnic Disparities in Multiple Myeloma: Moving Towards Inclusion or at a Standstill?

    Jul 1, 2022, 00:00

  • CO133 Initiation of Pharmacotherapies for Newly Diagnosed Early-Onset Idiopathic Restless Legs Syndrome from 2012-2019

    Jul 1, 2022, 00:00

  • EE456 Healthcare Resource Utilization Among Patients with Glycogen Storage Disease Type Ia (GSDIa) in the United States and the Impact of COVID-19: A Claims Database Analysis

    Jul 1, 2022, 00:00

  • EE26 Evaluation of the Cost in Patients with Chronic Obstructive Pulmonary Disease (COPD) Within the Public Health Perspective in Mexico

    Jul 1, 2022, 00:00

  • EPH160 Burden of Frequent Mental Distress in the US Population during the COVID-19 Pandemic

    Jul 1, 2022, 00:00

  • EE484 Evaluation of Health Care Resource Utilization and Costs Among Bio-Experienced Crohn's Disease Patients Treated with Biologics with Two Years of Follow-up

    Jul 1, 2022, 00:00

  • CO143 Impact of Perinatal Loss on Midwives

    Jul 1, 2022, 00:00

  • EE402 Is the Scope of Costs Considered in Budget Impact Analyses for Anticancer Drugs Rational? a Systematic Review and Comparative Study

    Jul 1, 2022, 00:00

  • EPH146 Prevalence of Urinary Incontinence Among Medicare Beneficiaries

    Jul 1, 2022, 00:00

  • CO124 Predictive Modeling for Suicide-Related Outcomes and Risk Factors Among Patients with Pain Conditions: A Systematic Review

    Jul 1, 2022, 00:00

  • CO13 The Effect of Preoperative Chest Physiotherapy on Oxygenation and Lung Functions Among Cardiac Surgery Patients: A Randomized Controlled Study

    Jul 1, 2022, 00:00

  • P19 Utilization of Low-Value and High-Value Care and Its Association with Cognitive Impairment

    Jul 1, 2022, 00:00

  • HPR62 Economic Evaluations of Public Health Interventions on COVID-19: A Systematic Review

    Jul 1, 2022, 00:00

  • HTA51 Unravelling the Rationale for the Source of External Control Arm in Single-Arm Oncology Submissions: What Is the Justification behind the Maze of Options?

    Jul 1, 2022, 00:00

  • EE490 The Budget Impact of Zanubrutinib for the Treatment of Waldenstrom's Macroglobulinemia in the United States

    Jul 1, 2022, 00:00

  • CO115 L-Arginine Supplemented Immunonutrition and Associated Health Outcomes in Critically Ill Patients

    Jul 1, 2022, 00:00

  • CO58 Long-Term Health Outcomes in Patients with Schizophrenia Treated with the Long-Acting Injectable Antipsychotic Aripiprazole Lauroxil for 1 Year

    Jul 1, 2022, 00:00

  • EPH9 Overall Mortality Among Patients with Hemophilia: A Systematic Review and Meta-Analysis

    Jul 1, 2022, 00:00

  • EPH103 COVID-19 Vaccination Among Pregnant Women in the US: A Systematic Review

    Jul 1, 2022, 00:00

  • HTA24 Orphan Drugs: What Is the Impact of Special Provisions in Value Assessment?

    Jul 1, 2022, 00:00

  • EE420 Use of a Cost-Tool to Support Decisions on Resource Allocation in the US Type 2 Diabetes Population Using Glucose Monitoring Devices

    Jul 1, 2022, 00:00

  • EE320 Budget Impact Analysis of Implementing a 23-Valent Pneumococcal Polysaccharide Vaccine in the Brazilian National Immunization Program for Adults 60 Years Old

    Jul 1, 2022, 00:00

  • HTA32 Characteristics of Data Sources and Inputs Used in Value and Health Technology Assessment Economic Evaluations: A Pilot Analysis

    Jul 1, 2022, 00:00

  • EE246 Cost-Effectiveness of OC/Lep Intervention for Treatment of Dysmenorrhea and Endometriosis in Japan

    Jul 1, 2022, 00:00

  • EE499 Budget Impact Analysis of Empagliflozin in Patients with Heart Failure in Sweden

    Jul 1, 2022, 00:00

  • HSD46 A Trend Analysis of Lupus Erythematosus Patients' Physician Office Visits and Medications Prescribed

    Jul 1, 2022, 00:00

  • HSD114 2010–2017 Trends of Neoadjuvant Chemotherapy Use Among Older Women with Breast Cancer: A SEER-Medicare Analysis

    Jul 1, 2022, 00:00

  • EPH149 Knowledge of Human Papillomavirus Among Women Aged between 25-65 YEARS in Hungary

    Jul 1, 2022, 00:00

  • EE134 Cost-Utility Analysis of Dapagliflozin in Patients with Heart Failure in Costa Rica

    Jul 1, 2022, 00:00

  • CO149 Effectiveness of Surface Modified Antimicrobial Implants in Treatment or Prevention of Periprosthetic Joint Infections Post Knee Replacement Surgery: A Systematic Literature Review

    Jul 1, 2022, 00:00

  • EE102 Economic Burden of Metastatic Castration-Resistant Prostate Cancer, By Line of Treatment, in Medicare Beneficiaries, 2014-2019

    Jul 1, 2022, 00:00

  • Table of Contents

    Jul 1, 2022, 00:00

  • EPH123 Epidemiological Disease Burden of Female Infertility Associated with Male Factors Based on Real-World Health Insurance Claims Data

    Jul 1, 2022, 00:00

  • EE248 Annual Health Insurance Treatment Cost of Unspecified Female Infertility Based on Real-World Health Insurance Claims Data

    Jul 1, 2022, 00:00

  • EE156 Marginal Health Care Expenditure of Patients with Non-Hodgkin Lymphoma: 2014-2019

    Jul 1, 2022, 00:00

  • The (Harsh) Reality of Real-World Data External Comparators for Health Technology Assessment

    Jul 1, 2022, 00:00

  • EE502 Economic Burden of Patients with Hemophilia in China

    Jul 1, 2022, 00:00

  • HSD2 Hidradenitis Suppurativa: Trends in Real-World Treatment Patterns in the United States

    Jul 1, 2022, 00:00

  • EE239 Reduction in Health Care-Related Costs after Initiation of Treatment with a Prescription Digital Therapeutic for Chronic Insomnia: Two-Year Follow up Analysis of Health Care Claims Data

    Jul 1, 2022, 00:00

  • CO156 Systematic Literature Review of the Efficacy and Safety of Infigratinib for the Treatment of Advanced Cholangiocarcinoma

    Jul 1, 2022, 00:00

  • EPH158 Years of Life Lost Due to Diabetes Mellitus in Colombia, 1979-2017

    Jul 1, 2022, 00:00

  • HSD80 Evaluation of Methotrexate Based Combinations in Rheumatoid Arthritis Patients: Results from a U.S. Administrative Claims Database

    Jul 1, 2022, 00:00

  • HSD42 Trends in Non-COVID Healthcare Utilization during the Pandemic in Lebanon

    Jul 1, 2022, 00:00

  • EE408 The Effect of Medical Innovation on the Cost-Effectiveness of COVID 19-Related Policies in the United States Using a Sir Model

    Jul 1, 2022, 00:00

  • HTA59 The Impact of the Patient Access Schemes on Appraisals for the Innovative Medicines in Scotland 2011-2020

    Jul 1, 2022, 00:00

  • EE334 Healthcare Utilization and Charges Associated with US Hospitalized Adult Patients with Coronavirus Disease 2019

    Jul 1, 2022, 00:00

  • EPH45 The Impact of Gingivitis and Periodontitis on COVID-19 Outcomes: A Case-Control Study

    Jul 1, 2022, 00:00

  • HPR10 Trends in FDA Approval of New Nervous System Drug 1980-2021

    Jul 1, 2022, 00:00

  • HSD34 Treatment Patterns and Healthcare-Resource Utilization Among Chronic Rhinosinusitis with Nasal Polyps Patients: In the New Era of Biologics

    Jul 1, 2022, 00:00

  • EPH8 Pregnancy Outcomes of Serotonin-Norepinephrine Reuptake Inhibitors (SNRI): Analysis of FDA Adverse Event Reporting System (FAERS) Database (2012-2021)

    Jul 1, 2022, 00:00

  • EE460 Predicting the Population Budget Impact of Current and New Listings for Melanoma: The PRIMCAT-MEL Model

    Jul 1, 2022, 00:00

  • HSD125 Geographic Variation of High-Risk Prescription Opioid Use Measures Among Disabled Medicare Beneficiaries, 2011-2018

    Jul 1, 2022, 00:00

  • HEOR Studies in Alzheimer's Disease and Related Dementias

    Jul 1, 2022, 00:00

  • EE436 Estimating the Potential Economic Impact of Tissue VS. Mechanical Surgical Replacement in Mainland China from a Societal Perspective

    Jul 1, 2022, 00:00

  • HPR60 Price Offers in Volume-Based Procurement in China and Their Determinants

    Jul 1, 2022, 00:00

  • CO19 Sintilimab Plus Chemotherapy for First-Line Treatment of Advanced or Metastatic Nonsquamous Non-Small-Cell Lung Cancer (AMNSQNSCLC): A Systematic Literature Review (SLR) and Network Meta-Analysis (NMA)

    Jul 1, 2022, 00:00

  • CO134 Impact of Pattern of Anticoagulant on Clinical Outcomes in Cancer Patients Who Had Atrial Fibrillation

    Jul 1, 2022, 00:00

  • Addressing the Impact of Social Determinants and Disparities on Health Outcomes

    Jul 1, 2022, 00:00

  • EE27 Comparing Alternative Paliperidone Formulations for Relapse Prevention in Patients with Schizophrenia: A Cost-Utility Analysis

    Jul 1, 2022, 00:00

  • HTA15 An Assessment of the Evidence Published Post-HTA for Selected HER2-Positive, Early Breast Cancer Medicines, to Address Potential HTA-Body Uncertainties

    Jul 1, 2022, 00:00

  • EE125 Cost-Effectiveness of Respiratory Syncytial Virus (RSV) Immunization Using Monoclonal Antibodies (mAB) in United States Infants: An Analysis of In-Season and out-of-Season Birth Cohorts

    Jul 1, 2022, 00:00

  • EE16 Chronic Kidney Disease in Type 2 Diabetes in Colombia: A Cost of Illness Analysis

    Jul 1, 2022, 00:00

  • P24 Predictors of Major Adverse Cardiovascular Events Among Type 2 Diabetes Mellitus Patients: A Machine Learning Time-to-Event Analysis

    Jul 1, 2022, 00:00

  • HTA6 Evaluation of Health State Utility Values (HSUV) Used in Health Technology Assessment (HTA) Submissions for Rare Diseases

    Jul 1, 2022, 00:00

  • HPR29 Racial Differences in Lifetime Healthcare Costs Associated with Obesity-Related Multimorbidity in the U.S. Adult Population Ages 40 Years and over

    Jul 1, 2022, 00:00

  • EE6 Contemporary Total Cost of Care Among Medicare Patients with Primary and Recurrent Clostridioides Difficile Infection

    Jul 1, 2022, 00:00

  • EE40 Economic Implications of Clinical Trials Enrollment in a Medicare Population

    Jul 1, 2022, 00:00

  • EPH46 Change in Persistence between Biologic and Biosimilar of Infliximab in the US

    Jul 1, 2022, 00:00

  • HSD22 Assessment of Drug-Drug Interactions and Their Associated Risk Factors Among Rheumatoid Arthritis Patients: A Cross-Sectional Study

    Jul 1, 2022, 00:00

  • EE56 Cost-Effectiveness Analysis of Motixafortide on Top of G-CSF for Stem Cell Mobilization for Autologous Bone Marrow Transplantation in Patients with Multiple Myeloma

    Jul 1, 2022, 00:00

  • Cost Effectiveness Analysis of Emerging Therapies/Technologies

    Jul 1, 2022, 00:00

  • EE485 Budget Impact of a Digital Wellness Intervention for Managing Depression and Anxiety: A Payer and Employer Perspective

    Jul 1, 2022, 00:00

  • Copyright/Subscription

    Jun 29, 2022, 08:39

  • Editorial Board

    Jun 3, 2022, 09:01

  • Leveraging the Similarities Between Cost-Effectiveness Analysis and Value-Based Healthcare

    Jun 1, 2022, 00:00

  • Stepwise Design and Evaluation of a Values-Oriented Ambient Intelligence Healthcare Monitoring Platform

    Jun 1, 2022, 00:00

  • Estimating Cost-Effectiveness Using Alternative Preference-Based Scores and Within-Trial Methods: Exploring the Dynamics of the Quality-Adjusted Life-Year Using the EQ-5D 5-Level Version and Recovering Quality of Life Utility Index [Editor's Choice]

    Jun 1, 2022, 00:00

  • Designing and Implementing Deliberative Processes for Health Technology Assessment: A Good Practices Report of a Joint HTAi/ISPOR Task Force [Editor's Choice]

    Jun 1, 2022, 00:00

  • Effectiveness of Pneumococcal Vaccines on Otitis Media in Children: A Systematic Review

    Jun 1, 2022, 00:00

  • One-Year Costs Associated With the Veterans Affairs National TeleStroke Program

    Jun 1, 2022, 00:00

  • Reported Challenges in Health Technology Assessment of Complex Health Technologies

    Jun 1, 2022, 00:00

  • Cost and Cost-Effectiveness of a Digital Adherence Technology for Tuberculosis Treatment Support in Uganda

    Jun 1, 2022, 00:00

  • Copyright/Subscription

    Jun 1, 2022, 00:00

  • Effectiveness and Cost-Effectiveness of 360 Disease-Modifying Treatment Escalation Sequences in Multiple Sclerosis [Editor's Choice]

    Jun 1, 2022, 00:00

  • Electronic Patient Symptom Management Program to Support Patients Receiving Cancer Treatment at Home During the COVID-19 Pandemic

    Jun 1, 2022, 00:00

  • A Cost-Utility Analysis of Remote Pulse-Oximetry Monitoring of Patients With COVID-19

    Jun 1, 2022, 00:00

  • Table of Contents

    Jun 1, 2022, 00:00

  • Accounting for Intergenerational Cascade Testing in Economic Evaluations of Clinical Genomics: A Scoping Review [Editor's Choice]

    Jun 1, 2022, 00:00

  • Cost-Effectiveness of Extracorporeal Photopheresis for the Treatment of Patients With Erythrodermic (Stage T4, M0) Cutaneous T-Cell Lymphoma in the Australian Setting

    Jun 1, 2022, 00:00

  • Comparison of Alternative Methods to Assess the Cost-Effectiveness of Tumor-Agnostic Therapies: A Triangulation Approach Using Larotrectinib as a Case Study

    Jun 1, 2022, 00:00

  • Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force

    Jun 1, 2022, 00:00

  • Economic Evaluation of Cognitive Behavioral Therapy for Depression: A Systematic Review [Editor's Choice]

    Jun 1, 2022, 00:00

  • Predicting Survival for Chimeric Antigen Receptor T-Cell Therapy: A Validation of Survival Models Using Follow-Up Data From ZUMA-1

    Jun 1, 2022, 00:00

  • Author's Reply

    Jun 1, 2022, 00:00

  • Optimizing the Design of a Repeated Fecal Immunochemical Test Bowel Cancer Screening Programme With a Limited Endoscopy Capacity From a Health Economic Perspective

    Jun 1, 2022, 00:00

  • Value of Magnetic Resonance Imaging Compared With Urine-Based Markers in the Detection of Prostate Cancer

    Jun 1, 2022, 00:00

  • Economic Evaluations of Remote Patient Monitoring for Chronic Disease: A Systematic Review

    Jun 1, 2022, 00:00

  • Long-Term Cost-Effectiveness Comparison of Catheter Ablation and Antiarrhythmic Drugs in Atrial Fibrillation Treatment Using Discrete Event Simulation

    Jun 1, 2022, 00:00

  • Assessing the Value of Remote Patient Monitoring Solutions in Addressing Challenges in Patient Care [Editor's Choice]

    Jun 1, 2022, 00:00

  • Instructions for Authors

    Jun 1, 2022, 00:00

  • Economic Evaluation of In-Hospital Clinical Practices in Acute Injury Care: A Systematic Review

    May 1, 2022, 00:00

  • The Cost-Effectiveness of Selective Internal Radiation Therapies Compared With Sorafenib for Treating Advanced Unresectable Hepatocellular Carcinoma in the United Kingdom

    May 1, 2022, 00:00

  • The Cost-Effectiveness of Remdesivir for Hospitalized Patients With COVID-19

    May 1, 2022, 00:00

  • Quantifying the Effect of Public Activity Intervention Policies on COVID-19 Pandemic Containment Using Epidemiologic Data From 145 Countries

    May 1, 2022, 00:00

  • Heterologous COVID-19 Vaccination in Spain: A Case Study of Individual Autonomy in the Real World

    May 1, 2022, 00:00

  • A Cost-Effectiveness Analysis of Remdesivir for the Treatment of Hospitalized Patients With COVID-19 in England and Wales

    May 1, 2022, 00:00

  • Copyright/Subscription

    May 1, 2022, 00:00

  • Effectiveness of Systemic Corticosteroids Therapy for Nonsevere Patients With COVID-19: A Multicenter, Retrospective, Longitudinal Cohort Study

    May 1, 2022, 00:00

  • Diagnostics and Treatments of COVID-19: A Living Systematic Review of Economic Evaluations

    May 1, 2022, 00:00

  • Are We Ready for a New Approach to Comparing Coverage and Reimbursement Policies for Medical Nutrition in Key Markets: An ISPOR Special Interest Group Report

    May 1, 2022, 00:00

  • Immunogenicity and Safety of the COVID-19 Vaccines Compared With Control in Healthy Adults: A Qualitative and Systematic Review

    May 1, 2022, 00:00

  • Editorial Board

    May 1, 2022, 00:00

  • Accounting for Unobservable Preference Heterogeneity and Evaluating Alternative Anchoring Approaches to Estimate Country-Specific EQ-5D-Y Value Sets: A Case Study Using Spanish Preference Data

    May 1, 2022, 00:00

  • Cost-Effectiveness of Systemic Treatments for Metastatic Castration-Sensitive Prostate Cancer: An Economic Evaluation Based on Network Meta-Analysis

    May 1, 2022, 00:00

  • Update on a Model to Minimize Population Health Loss in Times of Scarce Surgical Capacity During the COVID-19 Crisis and Beyond

    May 1, 2022, 00:00

  • Table of Contents

    May 1, 2022, 00:00

  • Economic Evaluation of Vaccination Programs: A Guide for Selecting Modeling Approaches [Editor's Choice]

    May 1, 2022, 00:00

  • COVID-19 Health Economics: Looking Back and Scoping the Future [Editor's Choice]

    May 1, 2022, 00:00

  • The Value of Federated Data Networks in Oncology: What Research Questions Do They Answer? Outcomes From a Systematic Literature Review [Editor's Choice]

    May 1, 2022, 00:00

  • Implementing Risk-Sharing Arrangements for Innovative Medicines: The Experience in Catalonia (Spain)

    May 1, 2022, 00:00

  • Quality-Adjusted Life-Years Lost Due to COVID-19 Mortality: Methods and Application for The Netherlands

    May 1, 2022, 00:00

  • Accounting for Preference Heterogeneity in Discrete-Choice Experiments: An ISPOR Special Interest Group Report [Editor's Choice]

    May 1, 2022, 00:00

  • The Effects of Severe Acute Respiratory Syndrome Coronavirus 2 on the Reported Mental Health Symptoms of Nonprofessional Carers: An Analysis Across Europe

    May 1, 2022, 00:00

  • Healthcare Resource Utilization of Patients With COVID-19 Visiting US Hospitals

    May 1, 2022, 00:00

  • Comparison of the PROMIS Preference Score (PROPr) and EQ-5D-5L Index Value in General Population Samples in the United Kingdom, France, and Germany

    May 1, 2022, 00:00

  • Cost-Effectiveness of Remdesivir for COVID-19 Treatment: What Are We Missing?

    May 1, 2022, 00:00

  • Cost-Effectiveness of Tumor Genomic Profiling to Guide First-Line Targeted Therapy Selection in Patients With Metastatic Lung Adenocarcinoma

    Apr 1, 2022, 00:00

  • US Food and Drug Administration Analysis of Patient-Reported Diarrhea and Its Impact on Function and Quality of Life in Patients Receiving Treatment for Breast Cancer

    Apr 1, 2022, 00:00

  • A Review of Patient-Reported Outcome Labeling of FDA-Approved New Drugs (2016-2020): Counts, Categories, and Comprehensibility [Editor's Choice]

    Apr 1, 2022, 00:00

  • Estimating and Extrapolating Survival Using a State-Transition Modeling Approach: A Practical Application in Multiple Myeloma

    Apr 1, 2022, 00:00

  • Parametric Survival Extrapolation of Early Survival Data in Economic Analyses: A Comparison of Projected Versus Observed Updated Survival

    Apr 1, 2022, 00:00

  • A Comparison of a Preliminary Version of the EQ-HWB Short and the 5-Level Version EQ-5D

    Apr 1, 2022, 00:00

  • Copyright/Subscription

    Apr 1, 2022, 00:00

  • Expanding the Scope of Value for Economic Evaluation: The EQ-HWB [Editor's choice]

    Apr 1, 2022, 00:00

  • Variation in Model-Based Economic Evaluations of Low-Dose Computed Tomography Screening for Lung Cancer: A Methodological Review

    Apr 1, 2022, 00:00

  • The Role of Indication-Based Pricing in Future Pricing and Reimbursement Policies: A Systematic Review

    Apr 1, 2022, 00:00

  • Rasch Analysis of the Michigan Hand Questionnaire

    Apr 1, 2022, 00:00

  • Table of Contents

    Apr 1, 2022, 00:00

  • Generation, Selection, and Face Validation of Items for a New Generic Measure of Quality of Life: The EQ-HWB

    Apr 1, 2022, 00:00

  • Barriers and Expectations for Patients in Post-Osteoporotic Fracture Care in France: The EFFEL Study

    Apr 1, 2022, 00:00

  • Cost and Quality of Life Outcomes of the STepped Exercise Program for Patients With Knee OsteoArthritis Trial

    Apr 1, 2022, 00:00

  • The History and Future of the “ISPOR Value Flower”: Addressing Limitations of Conventional Cost-Effectiveness Analysis [Editor's Choice]

    Apr 1, 2022, 00:00

  • The Development of a New International Generic Measure (EQ-HWB): Face Validity and Psychometric Stages in Argentina

    Apr 1, 2022, 00:00

  • Developing a New Generic Health and Wellbeing Measure: Psychometric Survey Results for the EQ-HWB

    Apr 1, 2022, 00:00

  • The EQ-HWB: Overview of the Development of a Measure of Health and Wellbeing and Key Results

    Apr 1, 2022, 00:00

  • Cost-Effectiveness Analysis of SAPIEN 3 Transcatheter Aortic Valve Implantation Procedure Compared With Surgery in Patients With Severe Aortic Stenosis at Low Risk of Surgical Mortality in France

    Apr 1, 2022, 00:00

  • Opportunities and Barriers to the Development and Use of Open Source Health Economic Models: A Survey [Editor's Choice]

    Apr 1, 2022, 00:00

  • Qualitative Review on Domains of Quality of Life Important for Patients, Social Care Users, and Informal Carers to Inform the Development of the EQ-HWB

    Apr 1, 2022, 00:00

  • Medicaid Expansion’s Impact on Emergency Department Use by State and Payer [Editor's Choice]

    Apr 1, 2022, 00:00

  • Editorial Board

    Mar 30, 2022, 09:26

  • Incentivizing Prescription Drug Switching to Reduce Patient and Health Plan Spending: A Microsimulation Model

    Mar 1, 2022, 00:00

  • Performance of the UK Prospective Diabetes Study Outcomes Model 2 in a Contemporary UK Type 2 Diabetes Trial Cohort

    Mar 1, 2022, 00:00

  • Economic Evaluation of National Patient Blood Management Clinical Guidelines in Cardiac Surgery

    Mar 1, 2022, 00:00

  • Copyright/Subscription

    Mar 1, 2022, 00:00

  • Assessing the Economic Value of Clinical Artificial Intelligence: Challenges and Opportunities [Editor's Choice]

    Mar 1, 2022, 00:00

  • Systematic Review of Health Economic Evaluations Focused on Artificial Intelligence in Healthcare: The Tortoise and the Cheetah [Editor's Choice]

    Mar 1, 2022, 00:00

  • Assessing Payers’ Preferences for Real-World Evidence in the United States: A Discrete Choice Experiment [Editor's Choice]

    Mar 1, 2022, 00:00

  • Reviewer Acknowledgment

    Mar 1, 2022, 00:00

  • A Framework for Using Real-World Data and Health Outcomes Modeling to Evaluate Machine Learning–Based Risk Prediction Models

    Mar 1, 2022, 00:00

  • Fulfilling the Promise of Artificial Intelligence in the Health Sector: Let’s Get Real

    Mar 1, 2022, 00:00

  • CDX2 Biomarker Testing and Adjuvant Therapy for Stage II Colon Cancer: An Exploratory Cost-Effectiveness Analysis

    Mar 1, 2022, 00:00

  • The Value of Artificial Intelligence for Healthcare Decision Making—Lessons Learned [Editor's Choice]

    Mar 1, 2022, 00:00

  • The Potential Cost-Effectiveness of a Machine Learning Tool That Can Prevent Untimely Intensive Care Unit Discharge

    Mar 1, 2022, 00:00

  • The Use of Cost-Effectiveness Thresholds for Evaluating Health Interventions in Low- and Middle-Income Countries From 2015 to 2020: A Review

    Mar 1, 2022, 00:00

  • Key Considerations in the Health Technology Assessment of Advanced Therapy Medicinal Products in Scotland, The Netherlands, and England [Editor's Choice]

    Mar 1, 2022, 00:00

  • Do People Favor Artificial Intelligence Over Physicians? A Survey Among the General Population and Their View on Artificial Intelligence in Medicine

    Mar 1, 2022, 00:00

  • Table of Contents

    Mar 1, 2022, 00:00

  • Estimating the Economic Value of CDX2 as a Predictive Biomarker to Guide Treatment Decisions in Stage II Colon Cancer

    Mar 1, 2022, 00:00

  • Investigating 5-Level EQ-5D (EQ-5D-5L) Values Based on Preferences of Patients With Heart Disease

    Mar 1, 2022, 00:00

  • Genetic-Guided Pharmacotherapy for Atrial Fibrillation: A Systematic and Critical Review of Economic Evaluations

    Mar 1, 2022, 00:00

  • Does Every Minute Really Count? Road Time as an Indicator for the Economic Value of Emergency Medical Services

    Mar 1, 2022, 00:00

  • Editorial Board

    Feb 28, 2022, 09:01

  • Approaches for Enhanced Extrapolation of Long-Term Survival Outcomes Using Electronic Health Records of Patients With Cancer

    Feb 1, 2022, 00:00

  • Copyright/Subscription

    Feb 1, 2022, 00:00

  • Estimating and Comparing Health and Financial Risk Protection Outcomes in Economic Evaluations

    Feb 1, 2022, 00:00

  • Is Ethylene-Vinyl Alcohol Copolymer Really as Cost-Effective as N-Butyl Cyanoacrylate Glue for Transcatheter Arterial Embolization of Gastrointestinal Bleeding in the United States and Outside?

    Feb 1, 2022, 00:00

  • Health State Utilities for Sickle Cell Disease: A Catalog Prepared From a Systematic Review

    Feb 1, 2022, 00:00

  • What Constitutes Preferred Long-Term Care Provided in Residential Aged Care Facilities? An Empirical Comparison of the Preferences of the General Population, Residents, and Family Members [Editor's Choice]

    Feb 1, 2022, 00:00

  • A Comparison of the Cost-Effectiveness of Lifestyle Interventions in Pregnancy

    Feb 1, 2022, 00:00

  • Heterogeneity in Radiotherapeutic Parameter Assumptions in Cost-Effectiveness Analyses in Prostate Cancer: A Call for Uniformity [Editor's Choice]

    Feb 1, 2022, 00:00

  • What Is Value in Health and Healthcare? A Systematic Literature Review of Value Assessment Frameworks [Editor's Choice]

    Feb 1, 2022, 00:00

  • Do You Recall?: Results From a Within-Person Recall Study of the Patient-Reported Outcomes Measurement Information System (PROMIS) Short Form v2.0 – Physical Function 8c

    Feb 1, 2022, 00:00

  • Using Virtual Reality Exposure Therapy in Pain Management: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

    Feb 1, 2022, 00:00

  • Cost-Effectiveness in Perioperative Care: Application of Markov Modeling to Pathways of Perioperative Care

    Feb 1, 2022, 00:00

  • How Can We Make More Rapid Progress in the Leveraging of Real-World Evidence by Regulatory Decision Makers? [Editor's Choice]

    Feb 1, 2022, 00:00

  • Cost-Effectiveness of Cemiplimab Versus Standard of Care in the United States for First-Line Treatment of Advanced Non-small Cell Lung Cancer With Programmed Death-Ligand 1 Expression ≥50%

    Feb 1, 2022, 00:00

  • Cost-Effectiveness of Posthospital Management of Acute Coronary Syndrome: A Real-World Investigation From Italy

    Feb 1, 2022, 00:00

  • Do Profit Margins of Pharmaceuticals Influence Reimbursement Decisions? A Discrete Choice Experiment Among Dutch Healthcare Decision Makers

    Feb 1, 2022, 00:00

  • Impact of Adding Oseltamivir to Usual Care on Quality-Adjusted Life-Years During Influenza-Like Illness

    Feb 1, 2022, 00:00

  • Table of Contents

    Feb 1, 2022, 00:00

  • Prioritizing Healthcare Interventions: A Comparison of Multicriteria Decision Analysis and Cost-Effectiveness Analysis [Editor's Choice]

    Feb 1, 2022, 00:00

  • Time Costs and Out-of-Pocket Costs in Patients With Chronic Hepatitis C in a Publicly Funded Health System

    Feb 1, 2022, 00:00

  • Editorial Board

    Jan 27, 2022, 09:58

  • Editorial Board

    Jan 3, 2022, 16:02

  • POSC180 Epidemiological Disease Burden of Left Ventricular Failure Based on Routinely Collected Health Insurance Claims Data

    Jan 1, 2022, 00:00

  • POSB412 Direct and Indirect Costs Associated with Chronic Lymphocytic Leukemia in Slovakia: 5 Years' Overview

    Jan 1, 2022, 00:00

  • POSB332 Comparison of Frozen Shoulder Syndrome Treatment Results Using Traditional and Functional Fasia Training Methods

    Jan 1, 2022, 00:00

  • POSC212 A Most-Similar Case Analysis of Gene Expression Test Reimbursement Assessment in Europe

    Jan 1, 2022, 00:00

  • POSA151 Cost-of-Illness in Adults with Diabetes Mellitus Type I in the Russian Federation

    Jan 1, 2022, 00:00

  • POSA320 Development of a Decision Algorithm for Fractional Polynomial (FP) Model Selection in Network Meta-Analysis (NMA): Why Statistical Fit Criteria Alone Is Not Enough

    Jan 1, 2022, 00:00

  • POSC95 The Economic Burden of Lung Cancer in China: A Systematic Literature Review

    Jan 1, 2022, 00:00

  • POSC52 Cost-Effectiveness of Atezolizumab in Association with Bevacizumab for Patients with Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC) Using a French Real-World Evidence Database

    Jan 1, 2022, 00:00

  • POSC362 Loss of Functionality and Low Scores on Quality-of-Life Scales in Obese and Non-Obese Sarcopenic Patients with Head and Neck Cancer: Cross-Sectional Study Based on Real Data World

    Jan 1, 2022, 00:00

  • POSA89 Annual Health Insurance Treatment Cost of Non-Insulin-Dependent Diabetes with Peripheral Circulatory Complications Based on Routinely Collected Financing Data

    Jan 1, 2022, 00:00

  • POSB205 Framework for Implementing Cost-Effectiveness Thresholds in Egypt

    Jan 1, 2022, 00:00

  • POSC58 Budget Impact of Pembrolizumab for Untreated or Unresectable Head and Neck Cancer in Ireland

    Jan 1, 2022, 00:00

  • POSB415 Predicting Factors of Complicated Ureteral Stent Removal in Patients with Kidney Stone in the United States

    Jan 1, 2022, 00:00

  • POSB306 Generative Adversarial Networks to Generate Synthetic Controls: A Real-World Data Example

    Jan 1, 2022, 00:00

  • POSC178 Identification of Heart Failure Subtypes within Patient Records: An Analysis of Linked Primary and Secondary Care Data in England

    Jan 1, 2022, 00:00

  • P28 Impact of COVID-19 on Mental Health in Young Adults in the United States

    Jan 1, 2022, 00:00

  • POSA33 Matching-Adjusted Indirect Comparisons of Avapritinib Versus Midostaurin Among Patients with Advanced Systemic Mastocytosis

    Jan 1, 2022, 00:00
  • «
  • 31
  • 32
  • 33
  • 34 (current)
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • »